These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29262643)

  • 21. Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats.
    Evert M; Sun J; Pichler S; Slavova N; Schneider-Stock R; Dombrowski F
    Cancer Res; 2004 Nov; 64(21):8093-100. PubMed ID: 15520221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells.
    Noordeen NA; Khera TK; Sun G; Longbottom ER; Pullen TJ; da Silva Xavier G; Rutter GA; Leclerc I
    Diabetes; 2010 Jan; 59(1):153-60. PubMed ID: 19833882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis.
    Bannasch P; Hacker HJ; Klimek F; Mayer D
    Adv Enzyme Regul; 1984; 22():97-121. PubMed ID: 6591771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma.
    Ribback S; Che L; Pilo MG; Cigliano A; Latte G; Pes GM; Porcu A; Pascale RM; Li L; Qiao Y; Dombrowski F; Chen X; Calvisi DF
    Cell Cycle; 2018; 17(12):1496-1512. PubMed ID: 29965794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic preneoplasia in hepatitis B virus transgenic mice.
    Toshkov I; Chisari FV; Bannasch P
    Hepatology; 1994 Nov; 20(5):1162-72. PubMed ID: 7927248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.
    Zhang D; Tong X; VanDommelen K; Gupta N; Stamper K; Brady GF; Meng Z; Lin J; Rui L; Omary MB; Yin L
    J Clin Invest; 2017 Jun; 127(7):2855-2867. PubMed ID: 28628040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
    Grefhorst A; Schreurs M; Oosterveer MH; Cortés VA; Havinga R; Herling AW; Reijngoud DJ; Groen AK; Kuipers F
    Biochem J; 2010 Dec; 432(2):249-54. PubMed ID: 20854262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperproliferative liver acini after intraportal islet transplantation in streptozotocin-induced diabetic rats.
    Dombrowski F; Lehringer-Polzin M; Pfeifer U
    Lab Invest; 1994 Nov; 71(5):688-99. PubMed ID: 7967522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.
    Zerban H; Radig S; Kopp-Schneider A; Bannasch P
    Carcinogenesis; 1994 Nov; 15(11):2467-73. PubMed ID: 7955093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism.
    Metzendorf C; Wineberger K; Rausch J; Cigliano A; Peters K; Sun B; Mennerich D; Kietzmann T; Calvisi DF; Dombrowski F; Ribback S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation.
    Tong X; Zhao F; Mancuso A; Gruber JJ; Thompson CB
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21660-5. PubMed ID: 19995986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.
    Denechaud PD; Bossard P; Lobaccaro JM; Millatt L; Staels B; Girard J; Postic C
    J Clin Invest; 2008 Mar; 118(3):956-64. PubMed ID: 18292813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
    Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
    J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.
    Nehrbass D; Klimek F; Bannasch P
    Am J Pathol; 1998 Feb; 152(2):341-5. PubMed ID: 9466558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity.
    Poungvarin N; Lee JK; Yechoor VK; Li MV; Assavapokee T; Suksaranjit P; Thepsongwajja JJ; Saha PK; Oka K; Chan L
    Diabetologia; 2012 Jun; 55(6):1783-96. PubMed ID: 22382520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrosomorpholine.
    Klimek F; Bannasch P
    Carcinogenesis; 1990 Aug; 11(8):1377-80. PubMed ID: 2387024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.
    Guinez C; Filhoulaud G; Rayah-Benhamed F; Marmier S; Dubuquoy C; Dentin R; Moldes M; Burnol AF; Yang X; Lefebvre T; Girard J; Postic C
    Diabetes; 2011 May; 60(5):1399-413. PubMed ID: 21471514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.